Open AccessEFFICIENCY OF PHARMACEUTICAL CONSUMPTION IN TURKEY: BENCHMARKING WITH OECD BY DEA
Author(s) -
Çağla Pınar Bozoklu,
Yasemin Keskin Benli
Publication year - 2018
Publication title -
business and management studies: an international journal
Language(s) - English
Resource type - Journals
ISSN - 2148-2586
DOI - 10.15295/bmij.v6i3.351
Subject(s) - benchmarking , consumption (sociology) , data envelopment analysis , life expectancy , position (finance) , index (typography) , business , total factor productivity , economics , marketing , productivity , economic growth , medicine , environmental health , finance , social science , statistics , mathematics , computer science , population , sociology , world wide web
After 1980s, consumers begin to focus more health-conscious behaviours and attitudes including the concept of consuming pharmaceutical products. Pharmaceutical consumption attitude is a natural outcome of this trend. In this research, it is aimed to analyze Turkey’s benchmarking position among OECD countries in terms of pharmaceutical consumption efficiency. 15 OECD countries’ 5 years (2008-2012) analyzed by DEA-Malmquist TFP with the output-oriented and variable returns to scale methods. TC index shows that Turkey had created more pharmaceutical consumption and longer life expectancy by using same amount of number of physicians, number of pharmacists, total public and private health insurance expenditures and number of doctor consultations. By the way, Turkey had embraced efficiency growth with the rate of 0.4 percent. However, total efficiency level of Turkey got damaged by reason of its administrative limitations.